Antisense Therapeutics Limited Stock Volatility
| ATHJF Stock | USD 0.04 0.00 0.00% |
Antisense Therapeutics is out of control given 3 months investment horizon. Antisense Therapeutics secures Sharpe Ratio (or Efficiency) of 0.12, which signifies that the company had a 0.12% return per unit of risk over the last 3 months. We are able to break down sixteen different technical indicators, which can help you to evaluate if expected returns of 4.72% are justified by taking the suggested risk. Use Antisense Therapeutics Risk Adjusted Performance of 0.0993, standard deviation of 39.12, and Mean Deviation of 9.72 to evaluate company specific risk that cannot be diversified away. Key indicators related to Antisense Therapeutics' volatility include:
30 Days Market Risk | Chance Of Distress | 30 Days Economic Sensitivity |
Antisense Therapeutics Pink Sheet volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Antisense daily returns, and it is calculated using variance and standard deviation. We also use Antisense's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Antisense Therapeutics volatility.
Antisense |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Antisense Therapeutics can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game as hey may decide to buy additional stocks of Antisense Therapeutics at lower prices to lower their average cost per share. Similarly, when the prices of Antisense Therapeutics' stock rise, investors can sell out and invest the proceeds in other equities with better opportunities.
Moving against Antisense Pink Sheet
| 0.65 | MKKGY | Merck KGaA ADR | PairCorr |
| 0.62 | MKGAF | MERCK Kommanditgesells | PairCorr |
| 0.52 | TAK | Takeda Pharmaceutical | PairCorr |
Antisense Therapeutics Market Sensitivity And Downside Risk
Antisense Therapeutics' beta coefficient measures the volatility of Antisense pink sheet compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Antisense pink sheet's returns against your selected market. In other words, Antisense Therapeutics's beta of 7.47 provides an investor with an approximation of how much risk Antisense Therapeutics pink sheet can potentially add to one of your existing portfolios. Antisense Therapeutics Limited is displaying above-average volatility over the selected time horizon. Antisense Therapeutics Limited is a penny stock. Although Antisense Therapeutics may be in fact a good investment, many penny pink sheets are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Antisense Therapeutics Limited. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Antisense instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
3 Months Beta |Analyze Antisense Therapeutics Demand TrendCheck current 90 days Antisense Therapeutics correlation with market (Dow Jones Industrial)Antisense Beta |
Antisense standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 39.72 |
It is essential to understand the difference between upside risk (as represented by Antisense Therapeutics's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Antisense Therapeutics' daily returns or price. Since the actual investment returns on holding a position in antisense pink sheet tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Antisense Therapeutics.
Antisense Therapeutics Pink Sheet Volatility Analysis
Volatility refers to the frequency at which Antisense Therapeutics pink sheet price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Antisense Therapeutics' price changes. Investors will then calculate the volatility of Antisense Therapeutics' pink sheet to predict their future moves. A pink sheet that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A pink sheet with relatively stable price changes has low volatility. A highly volatile pink sheet is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Antisense Therapeutics' volatility:
Historical Volatility
This type of pink sheet volatility measures Antisense Therapeutics' fluctuations based on previous trends. It's commonly used to predict Antisense Therapeutics' future behavior based on its past. However, it cannot conclusively determine the future direction of the pink sheet.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Antisense Therapeutics' current market price. This means that the pink sheet will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Antisense Therapeutics' to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Antisense Therapeutics Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Antisense Therapeutics Projected Return Density Against Market
Assuming the 90 days horizon the pink sheet has the beta coefficient of 7.4663 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Antisense Therapeutics will likely underperform.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Antisense Therapeutics or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Antisense Therapeutics' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Antisense pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Antisense Therapeutics Limited has an alpha of 3.6823, implying that it can generate a 3.68 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Predicted Return Density |
| Returns |
What Drives an Antisense Therapeutics Price Volatility?
Several factors can influence a pink sheet's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Antisense Therapeutics Pink Sheet Risk Measures
Assuming the 90 days horizon the coefficient of variation of Antisense Therapeutics is 841.39. The daily returns are distributed with a variance of 1577.93 and standard deviation of 39.72. The mean deviation of Antisense Therapeutics Limited is currently at 10.01. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.76
α | Alpha over Dow Jones | 3.68 | |
β | Beta against Dow Jones | 7.47 | |
σ | Overall volatility | 39.72 | |
Ir | Information ratio | 0.11 |
Antisense Therapeutics Pink Sheet Return Volatility
Antisense Therapeutics historical daily return volatility represents how much of Antisense Therapeutics pink sheet's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company shows 39.7232% volatility of returns over 90 . By contrast, Dow Jones Industrial accepts 0.7736% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Antisense Therapeutics Volatility
Volatility is a rate at which the price of Antisense Therapeutics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Antisense Therapeutics may increase or decrease. In other words, similar to Antisense's beta indicator, it measures the risk of Antisense Therapeutics and helps estimate the fluctuations that may happen in a short period of time. So if prices of Antisense Therapeutics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.Antisense Therapeutics Limited engages in the research and development of novel antisense pharmaceuticals in Australia. Antisense Therapeutics Limited was incorporated in 2000 and is based in Toorak, Australia. Antisense Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Antisense Therapeutics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Antisense Pink Sheet over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Antisense Therapeutics' price varies over time.
3 ways to utilize Antisense Therapeutics' volatility to invest better
Higher Antisense Therapeutics' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Antisense Therapeutics stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Antisense Therapeutics stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Antisense Therapeutics investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Antisense Therapeutics' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Antisense Therapeutics' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Antisense Therapeutics Investment Opportunity
Antisense Therapeutics Limited has a volatility of 39.72 and is 51.58 times more volatile than Dow Jones Industrial. Compared to the overall equity markets, volatility of historical daily returns of Antisense Therapeutics Limited is higher than 96 percent of all global equities and portfolios over the last 90 days. You can use Antisense Therapeutics Limited to protect your portfolios against small market fluctuations. The pink sheet experiences a normal downward fluctuation but is a risky buy. Check odds of Antisense Therapeutics to be traded at $0.0416 in 90 days.Average diversification
The correlation between Antisense Therapeutics Limited and DJI is 0.15 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Antisense Therapeutics Limited and DJI in the same portfolio, assuming nothing else is changed.
Antisense Therapeutics Additional Risk Indicators
The analysis of Antisense Therapeutics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Antisense Therapeutics' investment and either accepting that risk or mitigating it. Along with some common measures of Antisense Therapeutics pink sheet's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.0993 | |||
| Market Risk Adjusted Performance | 0.6218 | |||
| Mean Deviation | 9.72 | |||
| Coefficient Of Variation | 854.42 | |||
| Standard Deviation | 39.12 | |||
| Variance | 1530.04 | |||
| Information Ratio | 0.1138 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential pink sheets, we recommend comparing similar pink sheets with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Antisense Therapeutics Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Antisense Therapeutics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Antisense Therapeutics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Antisense Therapeutics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Antisense Therapeutics Limited.
Complementary Tools for Antisense Pink Sheet analysis
When running Antisense Therapeutics' price analysis, check to measure Antisense Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Antisense Therapeutics is operating at the current time. Most of Antisense Therapeutics' value examination focuses on studying past and present price action to predict the probability of Antisense Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Antisense Therapeutics' price. Additionally, you may evaluate how the addition of Antisense Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |